Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scienture Holdings (SCNX)
NASDAQ:SCNX
Holding SCNX?
Track your performance easily
SCNX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.69 - $44.56
Previous Close$7.35
Volume2.02K
Average Volume (3M)13.83K
Market Cap
$63.04M
Enterprise Value$64.95M
Total Cash (Recent Filing)$579.10K
Total Debt (Recent Filing)$2.49M
Price to Earnings (P/E)―
Beta2.19
Next Earnings
Jul 22, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jul 19, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-26.96
Shares Outstanding8,576,795
10 Day Avg. Volume7,293
30 Day Avg. Volume13,833
Standard Deviation0.39
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.84
Price to Sales (P/S)28.38
Price to Cash Flow (P/CF)-3.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue26.66
Enterprise Value/Gross Profit25.00
Enterprise Value/Ebitda-3.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Scienture Holdings News
PremiumCompany Announcements
Scienture Holdings Secures Funding for Strategic Growth
PremiumCompany Announcements
Scienture Holdings Shares Insight with Investor Presentation
PremiumCompany Announcements
Scienture Holdings Unveils New Identity Post-Merger
Ownership Overview
3.50% Insiders
0.17% Mutual Funds
― Other Institutional Investors
96.16% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SCNX FAQ
What was Scienture Holdings’s price range in the past 12 months?
Scienture Holdings lowest stock price was $3.69 and its highest was $44.56 in the past 12 months.
What is Scienture Holdings’s market cap?
Currently, no data Available
When is Scienture Holdings’s upcoming earnings report date?
Scienture Holdings’s upcoming earnings report date is Jul 22, 2024 which is 153 days ago.
How were Scienture Holdings’s earnings last quarter?
Currently, no data Available
Is Scienture Holdings overvalued?
According to Wall Street analysts Scienture Holdings’s price is currently Overvalued.
Does Scienture Holdings pay dividends?
Scienture Holdings pays a Notavailable dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Scienture Holdings dividends here
What is Scienture Holdings’s EPS estimate?
Scienture Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scienture Holdings have?
Scienture Holdings has 8,576,795 shares outstanding.
What happened to Scienture Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scienture Holdings?
Currently, no hedge funds are holding shares in SCNX
---
Scienture Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
108.86%
12-Months-Change
Fundamentals
Return on Equity
-384.13%
Trailing 12-Months
Asset Growth
296.49%
Trailing 12-Months
Company Description
Scienture Holdings
Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services; provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Land O' Lakes, FL.
---
SCNX Earnings Call
Q1 2023
0:00 / 0:00
---
Technical Analysis
---